Press Releases

Jan 11, 2021

Elicera Therapeutics recruits CFO

Read more
Jan 8, 2021

Elicera Therapeutics invitation to company presentation (in Swedish)

Read more
Oct 5, 2020

Elicera Therapeutics completes oversubscribed share issue and launches unique immuno-oncology company with focus on CAR T-cells and oncolytic viruses

Read more
Elicera Therapeutics AB is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.
Elicera Therapeutics AB (publ)
info@elicera.com
+46 (0)70-331 90 51‬